ClinConnect ClinConnect Logo
Search / Trial NCT06230042

Catheter in the Prevention of Urinary Tract Infections and Crystallization Study(CPUTICS)

Launched by SHANGHAI EAST HOSPITAL · Jan 27, 2024

Trial Information

Current as of August 25, 2025

Not yet recruiting

Keywords

Urinary Tract Infections Urinary Tract Crystallization

ClinConnect Summary

The Catheter in the Prevention of Urinary Tract Infections and Crystallization Study (CPUTICS) is a clinical trial that aims to compare two types of urinary catheters: Parylene-coated catheters and silicone catheters. The goal is to see which type of catheter better prevents urinary tract infections and the formation of crystals in the urine. This study is important because urinary catheters are often used in patients who need help urinating, and infections can be a serious concern.

To participate in this study, individuals must be at least 18 years old and have had a urinary catheter in place for at least 14 days. However, there are some conditions that may prevent someone from joining, such as having a urinary tract infection before starting the catheter or having certain medical issues like kidney problems or allergies to silicone. If eligible, participants will be asked to sign a consent form, which means they fully understand the study and agree to take part. Since this trial is not yet recruiting, more information will be available when it starts.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. age greater than 18 years;
  • 2. indwelling urinary catheter for ≥14 days;
  • 3. fully understand the clinical trial protocol and sign the informed consent;
  • Exclusion Criteria:
  • 1. patients with confirmed urinary tract infection before indwelling urinary catheter;
  • 2. those with renal dysfunction;
  • 3. those who are allergic to silicone or silicone material;
  • 4. those with low immunity susceptible to infection;
  • 5. those who have participated in other clinical trials within 3 months;
  • 6. others who are judged by the investigator to be unsuitable for clinical trials;

About Shanghai East Hospital

Shanghai East Hospital, affiliated with Tongji University, is a leading healthcare institution in China dedicated to providing high-quality medical services, education, and research. Renowned for its advanced clinical practices and cutting-edge technologies, the hospital plays a pivotal role in the advancement of medical science through innovative research and clinical trials. Committed to improving patient outcomes, Shanghai East Hospital collaborates with various stakeholders to explore new therapies and treatment modalities, enhancing the collective understanding of health and disease. Their clinical trial initiatives focus on addressing pressing medical needs while ensuring the highest ethical standards and patient safety.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

haifeng wang

Principal Investigator

Shanghai East Hospital,Tongji University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported